<DOC>
	<DOC>NCT01071278</DOC>
	<brief_summary>The aim of this observational program is to generate data on the use of Tredaptive (nicotinic acid/laropiprant) for lipid management under routine medical practice conditions.</brief_summary>
	<brief_title>Lipid Management in Clinical Practice (MK-0524A-115)</brief_title>
	<detailed_description />
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Lipid Metabolism Disorders</mesh_term>
	<criteria>Patients are 18 years of age or older with lipid disorder treated with nicotinic acid/laropiprant Patient is currently participating in a clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Lipid metabolism disorder</keyword>
</DOC>